7/21/2019 002_NDP.ppt

1/9

National Medicines Policies

Richard LaingPAR/PSM

Department of Medicines Policy and StandardsTBS 2005

7/21/2019 002_NDP.ppt

2/9

Department of Medicines Policy and StandardsTBS 2005

2 |

Objectives

Review the history of NDPs

Discuss the background to NDPs

List the Components of a NDP Review actors involved in the NDP

process

Debate characteristics of an NDP Discuss the Global Pharmaceutical

arket

7/21/2019 002_NDP.ppt

3/9

Department of Medicines Policy and StandardsTBS 2005

3 |

History of National Drug Policies

!"#$ Nairobi Conference of %&perts onrational 'se of Drugs

!"#( )orking group of %&perts to draftguidelines for NDPs

!"## Guidelines for NDPs released

!""$ %&pert Committee on NDPs met

report issued *++* New Guidelines published

7/21/2019 002_NDP.ppt

4/9

Department of Medicines Policy and StandardsTBS 2005

4 |

ac!ground to NDP"s

Need for common frameworkto coordinatemany di,erent actors in the pharmaceutical -eld.

/hese include regulators 01uality2 safety and

e3cacy42 producers 0local 5 international42 users0prescribers 5 consumers42 health planners 5managers2 health -nance authorities andresearchers6

%ach have valid interests in the -eld which maybe contradictory or supportive

7nvolves both public 5 private sectors

7/21/2019 002_NDP.ppt

5/9

Department of Medicines Policy and StandardsTBS 2005

5 |

#o$%onents of a NDP

Legislation2 Regulation and Guidelines

8election of Drugs

8upply 0incl6 procurement 5 production issues4

9uality :ssurance

Rational Drug 'se

%conomic 8trategies for Drugs

onitoring 5 %valuation of NDPs

Research

;uman Resources Development

/echnical Cooperation among Countries

7/21/2019 002_NDP.ppt

6/9

Department of Medicines Policy and StandardsTBS 2005

6 |

Overvie& of #o$%onents

%ach component has a crucial part in theoverall policy